Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
evaluation of the efficacy and safety of D-dimer adjusted heparin versus therapeutic dose heparin in patients with COVID-19 Pneumonia.
Description: All cause mortality
Measure: mortality Time: Until patient is discharged or up to 4 weeks whichever comes firstDescription: clinical signs supported by radiological evidence of arterial thrombosis or venous thromboembolism (e.g. venous or arterial duplex and CT scan of the chest with pulmonary angiography)
Measure: occurrence of venous and/or arterial thrombosis Time: Until patient is discharged or up to 4 weeks whichever comes firstDescription: calculation of sepsis induced coagulopathy (SIC) score
Measure: occurrence of Sepsis-induced coagulopathy Time: Until patient is discharged or up to 4 weeks whichever comes firstDescription: Calculation of partial pressure of arterial oxygen/ fraction of inspired oxygen (PaO2/ FIO2) ratio
Measure: Occurrence of adult respiratory distress syndrome (ARDS) Time: Until patient is discharged or up to 4 weeks whichever comes firstDescription: Calculation of sequential organ failure (SOFA) score
Measure: Occurrence of sepsis Time: Until patient is discharged or up to 4 weeks whichever comes firstDescription: occurrence of respiratory failure detected by arterial blood gases analysis
Measure: ICU admission and need for mechanical ventilation Time: Until patient is discharged or up to 4 weeks whichever comes firstAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports